Novo Nordisk's pricing strategies from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, stating the stark distinction involving U.S. costs and those in Europe and copyright.Novo Nordisk is associated with federal government funded collaborative investigation projects with other